TNF rs1800629: Understanding the -308 G>A Variant
The rs1800629 variant is a common genetic change located in the TNF gene, which provides instructions for making the tumor necrosis factor-alpha protein. This variant is frequently studied for its potential role in modulating inflammatory responses and its association with various immune-related conditions.
What each genotype means
Typical TNF-alpha production
This genotype is considered the wild-type or common form of the TNF gene promoter. Research suggests individuals with this genotype may have a more robust response to certain anti-TNF medications compared to those carrying the A allele. Please discuss any medication dosing or treatment efficacy concerns with your clinician or pharmacist.
This is the most common genotype globally, found in the majority of individuals across most ancestral populations.
Increased TNF-alpha potential
Carrying one copy of the A allele is associated with higher potential production of TNF-alpha compared to the GG genotype. Some studies suggest this may influence susceptibility to inflammatory conditions or alter the response to anti-TNF therapies, though evidence is mixed and can depend on other clinical factors. Always consult your healthcare provider regarding your specific treatment plan.
This heterozygous genotype is found in a significant minority of the population, with frequencies varying by ancestry.
High TNF-alpha potential
Individuals with this genotype may produce higher levels of TNF-alpha, which has been studied in the context of inflammatory and allergic responses. Research indicates that carriers of this genotype might experience a decreased response to certain anti-TNF inhibitor medications compared to those with the GG genotype. Please discuss these findings and your treatment options with your doctor or pharmacist.
This is the least common genotype, occurring in a small percentage of the global population.
What is the rs1800629 Variant?
The rs1800629 variant, often referred to as the -308 G>A polymorphism, is a single nucleotide polymorphism (SNP) located within the promoter region of the TNF gene on chromosome 6. In this variant, a guanine (G) nucleotide is replaced by an adenine (A) nucleotide. This specific location is critical because the promoter region acts as a control switch for gene expression. Research indicates that the presence of the A allele can influence the transcriptional activity of the TNF gene, potentially leading to higher production levels of the tumor necrosis factor-alpha (TNF-alpha) protein when the immune system is stimulated. Because TNF-alpha is a potent proinflammatory cytokine, even small changes in its production levels can have broad biological effects on various cell types, including leukocytes and vascular endothelium.
The Role of the TNF Gene
The TNF gene encodes tumor necrosis factor-alpha, a signaling protein involved in systemic inflammation and the acute phase reaction. It is a key player in the immune system, helping to regulate the activity of immune cells and facilitating the body's response to injury or infection. By promoting inflammation, TNF-alpha helps the body clear pathogens and initiate tissue repair. However, because it is such a powerful molecule, its production must be tightly regulated. When the balance of TNF-alpha production is disrupted, it can contribute to chronic inflammatory states. Variations like rs1800629 are of significant interest to researchers because they may alter the baseline or stimulated levels of this protein, potentially influencing an individual's susceptibility to inflammatory or autoimmune conditions.
Research and Associations
Scientific literature has explored the association between the rs1800629 variant and various health conditions, including asthma, celiac disease, and periodontitis. Meta-analyses have suggested that the A allele may be linked to an increased risk for these inflammatory conditions in certain populations, such as those of Asian or Caucasian descent. Additionally, some studies have investigated whether this variant influences how patients respond to specific anti-TNF therapies used for rheumatoid arthritis, with some evidence suggesting that genotype may correlate with treatment efficacy. It is important to note that these associations are often complex and inconsistent across different studies. The effect of a single genetic variant is typically modest, and the development of most inflammatory diseases is likely influenced by a combination of multiple genetic factors, environmental triggers, and lifestyle choices.
Interpreting Your Information
Understanding your genotype for rs1800629 provides insight into a specific area of your genetic makeup, but it does not serve as a medical diagnosis. Because the evidence linking this variant to specific diseases is often mixed or dependent on ancestry, it cannot be used to predict individual health outcomes with certainty. If you are concerned about inflammatory conditions or are considering treatment options, it is essential to consult with a qualified healthcare provider or a clinical geneticist. They can help interpret your results in the context of your overall health history and clinical symptoms. If you are currently taking medication, never make changes to your dosing or treatment plan based on genetic information without first discussing it with your clinician or pharmacist, as they are best equipped to manage your care.
How common is this variant?
The frequency of the A allele varies significantly across different global populations, with some studies noting higher prevalence in certain European and Asian cohorts compared to others.
Frequently asked questions
Does having the A allele mean I will develop an inflammatory disease?
No. Genetic variants like rs1800629 are only one of many factors that contribute to disease risk. Most people with the A allele do not develop these conditions, and many people without the allele do.
Can I use this information to change my medication?
You should never change your medication based on genetic test results alone. Always consult your doctor or pharmacist before making any adjustments to your prescribed treatment.
Is rs1800629 the same as TNF-alpha?
No. rs1800629 is a specific location in the DNA (a SNP) within the TNF gene. The TNF gene provides the instructions to create the TNF-alpha protein.
Why do study results for this variant seem inconsistent?
Genetic associations can vary due to differences in study design, the ancestry of the participants, and the influence of other environmental or genetic factors that interact with the TNF gene.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800629?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29